Sequential IL-2 and IL-2R levels predict rejection in liver allograft recipients.
Simpson
M A
MA
New England Deaconess Hospital, Harvard Medical School, Boston, Massachusetts 02215.
Young-Fadok
T
T
Madras
P N
PN
Freeman
R B
RB
Dempsey
R A
RA
Jenkins
R L
RL
Monaco
A P
AP
D001646:Bile / Q000378:metabolism; D003524:Cyclosporins / Q000009:adverse effects; D006084:Graft Rejection; D006801:Humans; D007376:Interleukin-2 / Q000097:blood / Q000378:metabolism* / Q000652:urine; D016031:Liver Transplantation / Q000276:immunology*; D015375:Receptors, Interleukin-2 / Q000097:blood / Q000378:metabolism* / Q000652:urine
D003524:Cyclosporins; D007376:Interleukin-2; D015375:Receptors, Interleukin-2